Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Life Insurance Strategies

Insurer Cuts Copayments For CFC-Free Inhalers

Your article was successfully shared with the contacts you provided.

The managed care division of UnitedHealth Group Inc. is trying to reduce out-of-pocket expenses for people with asthma who shift to medication delivery systems that are safer for the environment.

UnitedHealth, Minnetonka, Minn., has lowered the copayment for brand-name Xopenex HFA asthma medicine inhalers that are free of chlorofluorocarbon to the cheapest “tier,” or to $5 to $10 for members of most standard UnitedHealth prescription plans, the company says.

There is now a shortage of traditional CFC-containing inhalers, because the United States is trying to protect the Earth’s ozone layer by phasing out the CFCs in inhalers by Dec. 31, 2008, UnitedHealth says.

“The new CFC-free brand-name inhalers are just as effective but have a higher cost,” UnitedHealth says. “Physicians are recommending that asthma patients begin transitioning to the new CFC-free inhalers.”


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.